Right here’s the proof at New England Journal of Medication for tirzepatide for weight reduction. It’s a once-weekly injection. Value? Unknown to me.

At baseline, the imply physique weight was 104.eight kg, the imply BMI was 38.zero, and 94.5% of individuals had a BMI of 30 or larger. The imply share change in weight at week 72 was −15.zero% (95% confidence interval [CI], −15.9 to −14.2) with 5-mg weekly doses of tirzepatide, −19.5% (95% CI, −20.four to −18.5) with 10-mg doses, and −20.9% (95% CI, −21.eight to −19.9) with 15-mg doses and −three.1% (95% CI, −four.three to −1.9) with placebo (P<zero.zero01 for all comparisons with placebo). The share of individuals who had weight discount of 5% or extra was 85% (95% CI, 82 to 89), 89% (95% CI, 86 to 92), and 91% (95% CI, 88 to 94) with 5 mg, 10 mg, and 15 mg of tirzepatide, respectively, and 35% (95% CI, 30 to 39) with placebo; 50% (95% CI, 46 to 54) and 57% (95% CI, 53 to 61) of individuals within the 10-mg and 15-mg teams had a discount in physique weight of 20% or extra, as in contrast with three% (95% CI, 1 to five) within the placebo group (P<zero.zero01 for all comparisons with placebo).

Three to 7% of customers stopped the drug because of uncomfortable side effects.

Click on for a Diabetes Day by day article concerning the drug.

Steve Parker, M.D.

PS: I may also help you with weight reduction at much less value than tirzepatide. Purchase my ebook!